13 March 2018
Sarepta Therapeutics has announced its plans to submit a New Drug Application (NDA) for accelerated approval of its drug golodirsen (SRP-4053), a treatment for the neuromuscular disorder Duchenne Muscular Dystrophy...
8 March 2018
The US Food and Drug Administration (FDA) has approved Trogarzo (ibalizumab), a new antiretroviral medication for multidrug-resistant HIV (MDR-HIV).
16 February 2018
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s (J&J) next-generation prostate cancer drug apalutamide, to be sold under the brand name Erleada.
14 February 2018
The US Food and Drug Administration (FDA) has given its approval to Vertex’s combination treatment for cystic fibrosis (CF).
12 February 2018
The National Institute for Health and Care Excellence (NICE) has given its backing for EUSA Pharma’s drug Fotivda (tivozanib) as a first-line treatment for advanced renal cell carcinoma (RCC).
9 February 2018
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s (J&J) drug Zytiga (abiraterone acetate) in combination with prednisone as an effective treatment for metastatic high-risk castration-sensitive prostate...
19 October 2017
Biopharmaceutical firm MiMedx Group has obtained approval from the US Food and Drug Administration (FDA) for the initiation of its investigational new drug (IND) Phase IIb clinical trial of AmnioFix...
10 April 2017
The Scottish Medicines Consortium (SMC), UK, has approved the supply of Emtricitabine / tenofovir disoproxil (Truvada) by the National Health Service (NHS) to prevent HIV in the nation.
21 December 2016
Australian biotechnology firm Prima BioMed has secured approval from the UK’s Competent Authority and Ethics Committee to begin a Phase II b, active immunotherapy paclitaxel (AIPAC) trial of its IMP321...
1 December 2016
Teva Pharma Industries and Syqe Medical have entered an agreement to market medical cannabis inhalers in Israel.